Skip to main content

Table 2 Demographic and clinical data of the prostate cancer patients enrolled in this study (A) and Gleason score of biopsies (B)

From: Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection

A) Mean ± SD Range
Age (years) 66.31 ± 7.19 53 – 81
PSA (ng/mL) 7.82 ± 3.91 2.5 – 18.9
Prostate volume (cm3) 45.01 ± 17.23 22.02 – 91.11
B) Biopsy Gleason Score Number of biopy-proven cancer tissue (total = 61) % of total
3 + 3 37 60.7
3 + 4 9 14.7
4 + 3 7 11.5
4 + 4 6 9.8
4 + 5 2 3.3
  1. PSA prostate specific antigen